Lycopene attenuates inflammation and apoptosis in post.myocardial infarction remodeling by inhibiting the nuclear factor-κB signaling pathway

Molecular Medicine Reports

Volumn 11, Issue 1, 2015, Pages 374-378

  He, Qin ^a   Zhou, Wei ^a   Xiong, Caijin ^a   Tan, Gang ^a   Chen, Manhua ^a  

^a CENTRAL HOSPITAL OF WUHAN   (China)

Author keywords

Apoptosis; Inflammatory response; Lycopene; Myocardial infarction; Ventricular remodeling

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; COLLAGEN TYPE 1; COLLAGEN TYPE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LYCOPENE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; CAROTENOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART INFARCTION; HEART PROTECTION; HEART VENTRICLE REMODELING; INFLAMMATION; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; DISEASE MODEL; DRUG EFFECTS; HEART MUSCLE CELL; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY;

MUS;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CAROTENOIDS; DISEASE MODELS, ANIMAL; INFLAMMATION; MALE; MICE; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NF-KAPPA B; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 84916232246     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2676     Document Type: Article

References (41)

1. Sutton MG and Sharpe N: Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101: 2981-2988, 2000.
2. Frangogiannis NG, Smith CW and Entman ML: The infam-matory response in myocardial infarction. Cardiovasc Res 53: 31-47, 2002.
3. Dorn GW 2nd: Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc Res 1: 465-473, 2009.
4. Frantz S, Bauersachs J and Ertl G: Post-infarct remodelling: contribution of wound healing and infammation. Cardiovasc Res 81: 474-481, 2009.
5. Nian M, Lee P, Khaper N and Liu P: Infammatory cytokines and postmyocardial infarction remodeling. Circ Res 94: 1543-1553, 2004.
6. Koyama M, Kelly TR and Watanabe KA: Novel type of potential anticancer agents derived from chrysophanol and emodin. Some structure-activity relationship studies. J Med Chem 31: 283-284, 1988.
7. Sun M, Dawood F, Wen WH, Chen M, Dixon I, Kirshenbaum LA and Liu PP: Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction. Circulation 110: 3221-3228, 2004.
8. Baldi A, Abbate A, Bussani R, Patti G, Melf R, Angelini A, Dobrina A, Rossiello R, Silvestri F, Baldi F and Di Sciascio G: Apoptosis and post-infarction left ventricular remodeling. J Mol Cell Cardiol 34: 165-174, 2002.
9. Palojoki E, Saraste A, Eriksson A, Pulkki K, Kallajoki M, Voipio-Pulkki LM and Tikkanen I: Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 280: H2726-H2731, 2001.
10. Yeh CH, Chen T P, Wu YC, Lin YM and Jing Lin P: Inhibition of NFkappaB activation with curcumin attenuates plasma infam-matory cytokines surge and cardiomyocytic apoptosis following cardiac ischemia/reperfusion. J Surg Res 125: 109-116, 2005.
11. Yeh CH, Chen T P, Lee CH, Wu YC, Lin YM and Lin PJ: Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor alpha but not gamma activators. Shock 26: 262-270, 2006.
12. Wang M, Tsai BM, Reiger KM, Brown JW and Meldrum DR: 17-beta-Estradiol decreases p38 MAPK-mediated myocardial inflammation and dysfunction following acute ischemia. J Mol Cell Cardiol 40: 202-212, 2006.
13. Kopp EB and Ghosh S: NF-kappa B and rel proteins in innate immunity. Adv Immunol 58: 1-27, 1995.
14. Kanno T, Franzoso G and Siebenlist U: Human T-cell leukemia virus type I Tax-protein-mediated activation of NF-kappa B from p100 (NF-kappa B2)-inhibited cytoplasmic reservoirs. Proc Natl Acad Sci USA 91: 12634-12638, 1994.
15. Onai Y, Suzuki J, Maejima Y, Haraguchi G, Muto S, Itai A and Isobe M: Inhibition of NF-{kappa}B improves left ventricular remodeling and cardiac dysfunction after myocardial infarction. Am J Physiol Heart Circ Physiol 292: H530-H538, 2007.
16. Karppi J, Kurl S, Nurmi T, Rissanen TH, Pukkala E and Nyyssönen K: Serum lycopene and the risk of cancer: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) study. Ann Epidemiol 19: 512-518, 2009.
17. Riccioni G, Mancini B, Di Ilio E, Bucciarelli T and D'Orazio N: Protective effect of lycopene in cardiovascular disease. Eur Rev Med Pharmacol Sci 12: 183-190, 2008.
18. Parvin R and Akhter N: Protective effect of tomato against adrenaline-induced myocardial infarction in rats. Bangladesh Med Res Counc Bull 34: 104-108, 2008.
19. Upaganlawar A, Gandhi H and Balaraman R: Effect of vitamin E alone and in combination with lycopene on biochemical and histopathological alterations in isoproterenol-induced myocardial infarction in rats. J Pharmacol Pharmacother 1: 24-31, 2010.
20. Simone RE, Russo M, Catalano A, Monego G, Froehlich K, Boehm V and Palozza P: Lycopene inhibits NF-κB-mediated IL-8 expression and changes redox and PPARγ signalling in cigarette smoke-stimulated macrophages. PLoS One 6: e19652, 2011.
21. Gouranton E, Thabuis C, Riollet C, Malezet-Desmoulins C, El Yazidi C, Amiot MJ, Borel P and Landrier JF: Lycopene inhibits proinfammatory cytokine and chemokine expression in adipose tissue. J Nutr Biochem 22: 642-648, 2011.
22. Rajadurai M and Stanely Mainzen Prince P: Preventive effect of naringin on cardiac markers, electrocardiographic patterns and lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats. Toxicology 230: 178-188, 2007.
23. Lujan HL and DiCarlo SE: Mimicking the endogenous current of injury improves post-infarct cardiac remodeling. Med Hypotheses 81: 521-523, 2013.
24. Meloni M, Marchetti M, Garner K, Littlejohns B, Sala-Newby G, Xenophontos N, Floris I, Suleiman MS, Madeddu P, Caporali A and Emanueli C: Local inhibition of microRNA-24 improves reparative angiogenesis and left ventricle remodeling and function in mice with myocardial infarction. Mol Ther 21: 1390-1402, 2013.
25. Kanno Y, Watanabe R, Zempo H, Ogawa M, Suzuki J and Isobe M: Chlorogenic acid attenuates ventricular remodeling after myocardial infarction in mice. Int Heart J 54: 176-180, 2013.
26. Lei J, Xue S, Wu W, Zhou S, Zhang Y, Yuan G and Wang J: Sdc1 overexpression inhibits the p38 MAPK pathway and lessens fibrotic ventricular remodeling in MI rats. Inflammation 36: 603-615, 2013.
27. Morgia G, Cimino S, Favilla V, Russo GI, Squadrito F, Mucciardi G, Masieri L, Minutoli L, Grosso G and Castelli T: Effects of Serenoa repens, selenium and lycopene (Profuss®) on chronic infammation associated with benign prostatic hyper-plasia: results of?FLOG' (Flogosis and Profuss in Prostatic and Genital Disease), a multicentre Italian study. Int Braz J Urol 39: 214-221, 2013.
28. Renju GL, Muraleedhara Kurup G and Saritha Kumari CH: Anti-inflammatory activity of lycopene isolated from Chlorella marina on type II collagen induced arthritis in Sprague Dawley rats. Immunopharmacol Immunotoxicol 35: 282-291, 2013.
29. Hadad N and Levy R: The synergistic anti-infammatory effects of lycopene, lutein, β-carotene and carnosic acid combinations via redox-based inhibition of NF-κB signaling. Free Radic Biol Med 53: 1381-1391, 2012.
30. Abbate A and Narula J: Role of apoptosis in adverse ventricular remodeling. Heart Fail Clin 8: 79-86, 2012.
31. Singh SS and Kang PM: Mechanisms and inhibitors of apoptosis in cardiovascular diseases. Curr Pharm Des 17: 1783-1793, 2011.
32. Sinha K, Das J, Pal PB and Sil PC: Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch Toxicol 87: 1157-1180, 2013.
33. Delmas D, Solary E and Latruffe N: Resveratrol, a phyto-chemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe. Curr Med Chem 18: 1100-1121, 2011.
34. MacKenzie SH and Clark AC: Death by caspase dimerization. Adv Exp Med Biol 747: 55-73, 2012.
35. Moorjani N, Westaby S, Narula J, Catarino PA, Brittin R, Kemp TJ, Narula N and Sugden PH: Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure. Am J Cardiol 103: 1261-1268, 2009.
36. Satoh M, Minami Y, Takahashi Y and Nakamura M: Immune modulation: role of the infammatory cytokine cascade in the failing human heart. Curr Heart Fail Rep 5: 69-74, 2008.
37. Gao Y, Li T, Wu C, Bittle GJ, Chen S, Wu ZJ and Griffith BP: Pim-1 mediated signaling during the process of cardiac remodeling following myocardial infarction in ovine hearts. J Mol Cell Cardiol 63: 89-97, 2013.
38. Echtermeyer F, Harendza T, Hubrich S, Lorenz A, Herzog C, Mueller M, Schmitz M, Grund A, Larmann J, Stypmann J, Schieffer B, Lichtinghagen R, Hilfker-Kleiner D, Wollert KC, Heineke J and Theilmeier G: Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodelling. Cardiovasc Res 92: 123-131, 2011.
39. Hoesel B and Schmid JA: The complexity of NF-κB signaling in infammation and cancer. Mol Cancer 12: 86, 2013.
40. González A, Ravassa S, Beaumont J, López B and Díez J: New targets to treat the structural remodeling of the myocardium. J Am Coll Cardiol 58: 1833-1843, 2011.
41. Gordon JW, Shaw JA and Kirshenbaum LA: Multiple facets of NF-κB in the heart: to be or not to NF-κB. Circ Res 108: 1122-1132, 2011.